BackBotanix Pharmaceuticals Limited Overview

Botanix Pharmaceuticals Limited Total Liabilities

Track Botanix Pharmaceuticals Limited's total liabilities ($42M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$42.39M
↓ 11.30% YoYΔ $-5.40M vs prior year quarter

Peer trimmed avg / median

Loading

Botanix Pharmaceuticals Limited Total Liabilities History

Loading

Botanix Pharmaceuticals Limited vs. peers: Total Liabilities Comparison

Loading

Botanix Pharmaceuticals Limited Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Botanix Pharmaceuticals Limited (BOT.AX) FAQ

Botanix Pharmaceuticals Limited (BOT.AX) currently reports a total liabilities of $42M as of June 2026. That compares with $48M in the prior-year period — down 11.3% year over year. Use the charts on this page to explore Botanix Pharmaceuticals Limited's total liabilities history and peer comparisons.

Botanix Pharmaceuticals Limited's total liabilities decreased from $48M to $42M — a 11.3% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Botanix Pharmaceuticals Limited reported $42M in total liabilities as of June 2026. That compares with $48M in the prior-year period — down 11.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Botanix Pharmaceuticals Limited, and consider following BOT.AX for alerts when major investors trade the stock.

Botanix Pharmaceuticals Limited is classified in the Healthcare sector. On total liabilities, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BOT.AX with unrelated industries.